[Data Library (beta)]
: explore data packages specific to your use case and the included tables.
Discover More!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB09078
Lenvatinib
0
Recruiting
1
DB09037
Pembrolizumab
0
Recruiting
1
DB11740
Adavosertib
1
Active Not Recruiting
1
DB01101
Capecitabine
1
Not Yet Recruiting
1
DB14917
Ceralasertib
1
Recruiting
1
DB00531
Cyclophosphamide
1
Recruiting
1
DB01248
Docetaxel
1
Active Not Recruiting
1
DB01248
Docetaxel
1
Not Yet Recruiting
1
DB00544
Fluorouracil
1
Active Not Recruiting
1
DB00544
Fluorouracil
1
Not Yet Recruiting
1
DB00650
Leucovorin
1
Not Yet Recruiting
1
DB00526
Oxaliplatin
1
Active Not Recruiting
1
DB00526
Oxaliplatin
1
Not Yet Recruiting
1
DB01229
Paclitaxel
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Recruiting
1
DB00020
Sargramostim
1
Recruiting
1
DB14962
Trastuzumab deruxtecan
1
Recruiting
1
DB00531
Cyclophosphamide
1 / 2
Completed
1
DB05643
IRX-2
1 / 2
Completed
1
DB09037
Pembrolizumab
1 / 2
Completed
1
DB15233
Avapritinib
2
Recruiting
1
DB11105
Benzalkonium
2
Recruiting
1
DB00958
Carboplatin
2
Active Not Recruiting
1
DB00544
Fluorouracil
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB09078
Lenvatinib
2
Active Not Recruiting
1
DB06599
Lexatumumab
2
Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB00526
Oxaliplatin
2
Active Not Recruiting
2
DB01229
Paclitaxel
2
Active Not Recruiting
1
DB01229
Paclitaxel
2
Recruiting
1
DB09037
Pembrolizumab
2
Active Not Recruiting
1
DB05578
Ramucirumab
2
Recruiting
1
DB08937
TAS-102
2
Recruiting
1
DB04485
Thymidine
2
Active Not Recruiting
1
DB09343
Tipiracil
2
Active Not Recruiting
1
DB09343
Tipiracil
2
Recruiting
1
DB00432
Trifluridine
2
Active Not Recruiting
1
DB00432
Trifluridine
2
Recruiting
1
DB00543
Amoxapine
3
Recruiting
1
DB00958
Carboplatin
3
Recruiting
1
DB01248
Docetaxel
3
Recruiting
1
DB00544
Fluorouracil
3
Recruiting
1
DB01229
Paclitaxel
3
Recruiting
1